{"id":"https://openalex.org/W2032053799","doi":"https://doi.org/10.1016/s0924-9338(02)00705-8","title":"Use of antipsychotic agents in Spain through 1985\u20132000","display_name":"Use of antipsychotic agents in Spain through 1985\u20132000","publication_year":2002,"publication_date":"2002-12-01","ids":{"openalex":"https://openalex.org/W2032053799","doi":"https://doi.org/10.1016/s0924-9338(02)00705-8","mag":"2032053799","pmid":"https://pubmed.ncbi.nlm.nih.gov/12504264"},"language":"en","primary_location":{"id":"doi:10.1016/s0924-9338(02)00705-8","doi":"https://doi.org/10.1016/s0924-9338(02)00705-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0924-9338(02)00705-8","pdf_url":null,"source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085583993","display_name":"Blanca Santamar\u00eda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142787","display_name":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","ror":"https://ror.org/043fs9135","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210098440","https://openalex.org/I4210142787"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Blanca Santamar\u00eda","raw_affiliation_strings":["Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia, Agencia Espa\u00f1ola del Medicamento, Ctra. de Majadahonda-Pozuelo, Km 2, 28220, Spain","Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia, Agencia Espa\u00f1ola del Medicamento, Ctra. de Majadahonda-Pozuelo, Km 2, 28220, Majadahonda (Madrid), Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia, Agencia Espa\u00f1ola del Medicamento, Ctra. de Majadahonda-Pozuelo, Km 2, 28220, Spain","institution_ids":["https://openalex.org/I4210142787"]},{"raw_affiliation_string":"Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia, Agencia Espa\u00f1ola del Medicamento, Ctra. de Majadahonda-Pozuelo, Km 2, 28220, Majadahonda (Madrid), Spain","institution_ids":["https://openalex.org/I4210142787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067313760","display_name":"Magdalena P\u00e9rez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142787","display_name":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","ror":"https://ror.org/043fs9135","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210098440","https://openalex.org/I4210142787"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Magdalena P\u00e9rez","raw_affiliation_strings":["Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia, Agencia Espa\u00f1ola del Medicamento, Ctra. de Majadahonda-Pozuelo, Km 2, 28220, Majadahonda (Madrid), Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia, Agencia Espa\u00f1ola del Medicamento, Ctra. de Majadahonda-Pozuelo, Km 2, 28220, Majadahonda (Madrid), Spain","institution_ids":["https://openalex.org/I4210142787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113904087","display_name":"Dolores Montero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142787","display_name":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","ror":"https://ror.org/043fs9135","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210098440","https://openalex.org/I4210142787"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Dolores Montero","raw_affiliation_strings":["Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia, Agencia Espa\u00f1ola del Medicamento, Ctra. de Majadahonda-Pozuelo, Km 2, 28220, Majadahonda (Madrid), Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia, Agencia Espa\u00f1ola del Medicamento, Ctra. de Majadahonda-Pozuelo, Km 2, 28220, Majadahonda (Madrid), Spain","institution_ids":["https://openalex.org/I4210142787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003506739","display_name":"Mariano Madurga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142787","display_name":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","ror":"https://ror.org/043fs9135","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210098440","https://openalex.org/I4210142787"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mariano Madurga","raw_affiliation_strings":["Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia, Agencia Espa\u00f1ola del Medicamento, Ctra. de Majadahonda-Pozuelo, Km 2, 28220, Majadahonda (Madrid), Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia, Agencia Espa\u00f1ola del Medicamento, Ctra. de Majadahonda-Pozuelo, Km 2, 28220, Majadahonda (Madrid), Spain","institution_ids":["https://openalex.org/I4210142787"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086869616","display_name":"Francisco Jos\u00e9 de Abajo","orcid":"https://orcid.org/0000-0001-9119-8646","observed_orcids":["https://orcid.org/0000-0001-9119-8646"]},"institutions":[{"id":"https://openalex.org/I4210142787","display_name":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","ror":"https://ror.org/043fs9135","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210098440","https://openalex.org/I4210142787"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Francisco J de Abajo","raw_affiliation_strings":["Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia, Agencia Espa\u00f1ola del Medicamento, Ctra. de Majadahonda-Pozuelo, Km 2, 28220, Majadahonda (Madrid), Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia, Agencia Espa\u00f1ola del Medicamento, Ctra. de Majadahonda-Pozuelo, Km 2, 28220, Majadahonda (Madrid), Spain","institution_ids":["https://openalex.org/I4210142787"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5113904087"],"corresponding_institution_ids":["https://openalex.org/I4210142787"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":null,"fwci":3.0839,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.90804659,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"17","issue":"8","first_page":"471","last_page":"476"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/3207","display_name":"Social Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12666","display_name":"Historical Psychiatry and Medical Practices","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.921999990940094},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.9419999718666077},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.8889999985694885},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9890000224113464},{"id":"https://openalex.org/keywords/typical-antipsychotics","display_name":"typical antipsychotics","score":0.9129999876022339},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9259999990463257},{"id":"https://openalex.org/keywords/fluphenazine","display_name":"fluphenazine","score":0.9049999713897705},{"id":"https://openalex.org/keywords/thioridazine","display_name":"thioridazine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/defined-daily-doses","display_name":"defined daily doses","score":0.6959999799728394},{"id":"https://openalex.org/keywords/drug-use-trends","display_name":"drug use trends","score":0.6990000009536743},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.5979999899864197},{"id":"https://openalex.org/keywords/spain","display_name":"Spain","score":0.6209999918937683},{"id":"https://openalex.org/keywords/nordic-comparison","display_name":"Nordic comparison","score":0.9269999861717224}],"concepts":[{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.8401638269424438},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.8087441921234131},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.7877489924430847},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7678576707839966},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.7002114057540894},{"id":"https://openalex.org/C2776978879","wikidata":"https://www.wikidata.org/wiki/Q58376","display_name":"Fluphenazine","level":4,"score":0.6782033443450928},{"id":"https://openalex.org/C2776865356","wikidata":"https://www.wikidata.org/wiki/Q1182681","display_name":"Defined daily dose","level":3,"score":0.6560828685760498},{"id":"https://openalex.org/C521751864","wikidata":"https://www.wikidata.org/wiki/Q1729207","display_name":"Christian ministry","level":2,"score":0.5547439455986023},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5320742130279541},{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.47458481788635254},{"id":"https://openalex.org/C2780688371","wikidata":"https://www.wikidata.org/wiki/Q58375","display_name":"Thioridazine","level":3,"score":0.45518869161605835},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4533277750015259},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.40444105863571167},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3733486533164978},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24608883261680603},{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.19672822952270508},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.13598588109016418},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12362921237945557},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013030","descriptor_name":"Spain","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0924-9338(02)00705-8","doi":"https://doi.org/10.1016/s0924-9338(02)00705-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0924-9338(02)00705-8","pdf_url":null,"source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},{"id":"pmid:12504264","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12504264","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European psychiatry : the journal of the Association of European Psychiatrists","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W162839210","https://openalex.org/W616158002","https://openalex.org/W1895992443","https://openalex.org/W2019333296","https://openalex.org/W2031786430","https://openalex.org/W2081559589","https://openalex.org/W2085360366","https://openalex.org/W2088879645","https://openalex.org/W2092416470","https://openalex.org/W2096635847","https://openalex.org/W2115115146","https://openalex.org/W2153226419","https://openalex.org/W2416991392","https://openalex.org/W2441454412","https://openalex.org/W2921717319","https://openalex.org/W4252834865","https://openalex.org/W4285719527","https://openalex.org/W6680921537"],"related_works":["https://openalex.org/W3025683073","https://openalex.org/W2171529513","https://openalex.org/W7217273501","https://openalex.org/W7215109041","https://openalex.org/W7125683754","https://openalex.org/W2531357462","https://openalex.org/W3127369034","https://openalex.org/W7169881053","https://openalex.org/W7000327906","https://openalex.org/W2934095449"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1,78],"analyze":[2],"the":[3,16,22,37,41,48,58,80,90,138,151,159,178,199,218,231],"trend":[4],"of":[5,18,40,44,53,82,110,130,132,172,180,201,233],"antipsychotic":[6,32],"drug":[7,234],"consumption":[8,24,33],"in":[9,112,120,126,157,174,192,195,210,230],"Spain":[10,113,193,211,221],"from":[11,36,89,99,104,116,236],"1985":[12,121,237],"to":[13,122,185,238],"2000,":[14,158],"and":[15,25,145,168,222],"impact":[17,81],"atypical":[19,83],"antipsychotics":[20,84,111],"on":[21,26,31,85],"overall":[23],"clozapine":[27,86,184],"use.":[28],"METHODS:":[29],"Data":[30,62],"were":[34,95,102,150,165],"drawn":[35],"ECOM":[38],"database":[39],"Spanish":[42,91],"Ministry":[43],"Health,":[45],"which":[46],"contains":[47],"retail":[49],"community":[50],"pharmacies":[51],"sales":[52],"medicinal":[54],"products":[55],"reimbursed":[56],"by":[57],"National":[59],"Health":[60],"System.":[61],"are":[63],"presented":[64],"as":[65],"defined":[66],"daily":[67],"doses":[68],"(DDDs)":[69],"per":[70,73],"1000":[71],"inhabitants":[72],"day,":[74],"for":[75],"each":[76],"year.":[77],"evaluate":[79],"use,":[87],"data":[88,98],"\"Clozapine":[92],"Monitoring":[93],"Program\"":[94],"analyzed.":[96],"Consumption":[97],"Nordic":[100,196],"countries":[101,225],"obtained":[103],"national":[105],"statistics.":[106],"RESULTS:":[107],"The":[108,128,170],"use":[109,131,188,209,235],"increased":[114,213],"progressively":[115,214],"1.51":[117],"DDD/1000":[118,124],"inhabitants/d":[119,125],"5.73":[123],"2000.":[127],"pattern":[129,232],"individual":[133],"drugs":[134,152,161],"changed":[135],"greatly":[136],"over":[137],"study":[139],"period.":[140],"In":[141],"1985,":[142,216],"haloperidol,":[143],"fluphenazine":[144],"thioridazine,":[146],"all":[147],"typical":[148],"antipsychotics,":[149],"most":[153,162],"widely":[154],"used,":[155],"whereas":[156],"three":[160],"frequently":[163],"used":[164],"risperidone,":[166],"olanzapine":[167,173],"haloperidol.":[169],"introduction":[171],"December":[175],"1996":[176],"reduced":[177],"number":[179],"new":[181],"treatments":[182],"with":[183],"half.":[186],"Antipsychotic":[187,207],"is":[189],"still":[190],"lower":[191],"than":[194],"countries,":[197],"despite":[198],"prevalence":[200],"schizophrenia":[202],"being":[203],"similar":[204],"worldwide.":[205],"CONCLUSIONS:":[206],"agent":[208],"has":[212],"since":[215],"reducing":[217],"differences":[219,229],"between":[220],"other":[223],"European":[224],"(Nordic":[226],"countries).":[227],"Substantial":[228],"2000":[239],"have":[240],"been":[241],"observed.":[242]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}